Navigation Links
The American Society for Microbiology honors Alison Criss
Date:9/13/2011

Alison K. Criss, Ph.D., University of Virginia, Charlottesville, has been chosen by the American Society for Microbiology (ASM) to receive a 2011 ICAAC Young Investigator Award for her outstanding research on bacterial pathogenesis. Sponsored by Merck, U.S. Human Health Division, this award recognizes an early career scientist for research excellence in microbiology and infectious diseases.

Dr. Criss received her Ph.D. from Harvard University and completed her postdoctoral fellowship at Northwestern University. She was nominated by her postdoctoral advisor, H. Steven Seifert, Fellow of the American Academy of Microbiology, who describes Dr. Criss as an "extremely intelligent, insightful, diligent, meticulous, hard working person who tackles problems head-on."

Dr. Criss is currently an Assistant Professor in the Department of Microbiology at the University of Virginia, where she studies the interactions of Neisseria gonorrhoeae with PMNs in her laboratory at the University of Virginia. A supporter of her nomination, Joanna Goldberg, Academy Fellow from the University of Virginia, describes Dr. Criss as "truly a rising young star [who] has a very professional and enthusiastic manner that serves to engage and inspire students to perform at the best of their ability."

Dr. Criss' research focuses on the interplay between bacterial pathogens and host cells at mucosal surfaces. Her graduate work explored the regulation of Salmonella pathogenesis by Rho and ARF family GTPases in polarized epithelial cells. As a postdoctoral fellow at Northwestern, Dr. Criss investigated the robust mechanisms by which N. gonorrhoeae avoids immune recognition and clearance. N. gonorrhoeae evades humoral immunity by varying its surface components, including antigenic variation of the type IV pilus. She used high-throughput DNA sequencing to show that pilin antigenic variation occurs at the highest frequency of any known pathogenic gene conversion system and produces a diverse repertoire of pilin proteins, as observed during human disease. N. gonorrhoeae also survives exposure to neutrophils in gonorrheal secretions, for reasons that are poorly understood. Using a primary human neutrophil infection model, Dr. Criss demonstrated that N. gonorrhoeae suppresses neutrophil production of reactive oxidative species and encodes gene products that confer resistance to neutrophils' non-oxidative antimicrobial activities. Her laboratory at the University of Virginia is elucidating the molecular and cellular interactions between N. gonorrhoeae and neutrophils, with the goals of identifying the antimicrobial activities neutrophils direct against N. gonorrhoeae and the bacterial defenses that subvert them.

William Shafer, Academy Fellow from Emory University and supporter of Dr. Criss' nomination, says "I have been most favorably impressed by the rigor that Dr. Criss applies to her work, the depth of her thought processes, and her willingness to freely exchange ideas and reagents She has performed the most convincing (and elegant) work to date that shows N. gonorrhoeae can resist intraleukocytic killing by human PMNs."


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. News from the October 2008 Journal of the American Dietetic Association
2. American Chemical Societys Weekly PressPac -- Sept. 24, 2008
3. Nanotech and synbio: Americans dont know whats coming
4. American Chemical Societys Weekly PressPac
5. American College of Medical Genetics receives $13.5M NIH contract
6. The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia
7. American Chemical Society Weekly PressPac Oct. 15, 2008
8. Scientists map soils on an extinct American volcano
9. Indiana University research at American Public Health Association meeting
10. North American environmental commission launches trinational vaquita conservation plan
11. News from the November 2008 Journal of the American Dietetic Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/28/2017)... , February 28, 2017 News solutions for ... ... from 14 to 16 March, Materna will present ... show how seamless travel is a real benefit for passengers. ... biometrics to their passenger touch point solutions to take passengers through ...
(Date:2/26/2017)... Feb. 25, 2017  Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring, announces ... Reentry. "Too often, too many offenders ... county jails are trying to tackle this ongoing ... friends and family members. While significant steps are underway, ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017 In ... four equities in the Biotech industry: Sangamo Therapeutics Inc. ... Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from ... their free report at: ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
(Date:3/22/2017)... LEXINGTON, Mass. , March 22, 2017   ... collections, today announced that Doctors Pathology Service ... mid-Atlantic region of the United States ... the Delaware Health Information Network (DHIN) to ... researchers. The novel program, announced in ...
(Date:3/22/2017)... 22, 2017   Boston Biomedical , an industry ... to target cancer stemness pathways, today announced its Board ... as Chief Executive Officer, effective April 24, 2017. ... Li , M.D., FACP, who has led Boston Biomedical ... his leadership, Boston Biomedical has grown from a "garage ...
Breaking Biology Technology: